Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)May 31, 2025 | (Q2)Feb 28, 2025 | (Q1)Nov 30, 2024 | (FY)Aug 31, 2024 | (Q4)Aug 31, 2024 | (Q3)May 31, 2024 | (Q2)Feb 29, 2024 | (Q1)Nov 30, 2023 | (FY)Aug 31, 2023 | (Q4)Aug 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -24.10%12.43K | 336.02%146.01K | 1,286.92%159.72K | 10.91%206.56K | 574.96%145.18K | 3.35%16.37K | -74.12%33.49K | -40.98%11.52K | 101.16%186.24K | -50.90%21.51K |
| Selling and administrative expenses | -24.99%8.67K | 499.55%135.8K | 1,443.71%133.36K | 4.58%176.76K | 575.72%133.91K | -16.93%11.56K | -80.71%22.65K | -51.58%8.64K | 238.17%169.02K | -35.94%19.82K |
| -Selling and marketing expense | --0 | --63.57K | --53.36K | --17.9K | --17.9K | --0 | --0 | --0 | --0 | ---- |
| -General and administrative expense | -24.99%8.67K | 218.91%72.24K | 826.03%80K | -6.01%158.87K | 485.42%116.02K | -16.93%11.56K | -80.71%22.65K | -51.58%8.64K | 238.17%169.02K | -35.94%19.82K |
| Other operating expenses | -21.97%3.76K | -5.78%10.21K | 816.13%26.36K | 73.07%29.8K | 566.02%11.27K | 149.48%4.82K | -9.13%10.84K | 72.38%2.88K | -59.59%17.22K | -86.86%1.69K |
| Operating profit | 24.10%-12.43K | -336.02%-146.01K | -1,286.92%-159.72K | -10.91%-206.56K | -574.96%-145.18K | -3.35%-16.37K | 74.12%-33.49K | 40.98%-11.52K | -101.16%-186.24K | 50.90%-21.51K |
| Net non-operating interest income (expenses) | ||||||||||
| Other net income (expenses) | -1.49K | 3.37K | -2.56K | |||||||
| Gain on sale of security | ---1.49K | --3.37K | ---2.56K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Income before tax | 14.99%-13.92K | -325.96%-142.65K | -1,309.15%-162.28K | -10.91%-206.56K | -574.96%-145.18K | -3.35%-16.37K | 74.12%-33.49K | 40.98%-11.52K | -254.17%-186.24K | -464.57%-21.51K |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | 14.99%-13.92K | -325.96%-142.65K | -1,309.15%-162.28K | -10.91%-206.56K | -574.96%-145.18K | -3.35%-16.37K | 74.12%-33.49K | 40.98%-11.52K | -254.17%-186.24K | -464.57%-21.51K |
| Net income continuous operations | 14.99%-13.92K | -325.96%-142.65K | -1,309.15%-162.28K | -10.91%-206.56K | -574.96%-145.18K | -3.35%-16.37K | 74.12%-33.49K | 40.98%-11.52K | -254.17%-186.24K | -464.57%-21.51K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 14.99%-13.92K | -325.96%-142.65K | -1,309.15%-162.28K | -10.91%-206.56K | -574.96%-145.18K | -3.35%-16.37K | 74.12%-33.49K | 40.98%-11.52K | -254.17%-186.24K | -464.57%-21.51K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 14.99%-13.92K | -325.96%-142.65K | -1,309.15%-162.28K | -10.91%-206.56K | -574.96%-145.18K | -3.35%-16.37K | 74.12%-33.49K | 40.98%-11.52K | -254.17%-186.24K | -464.57%-21.51K |
| Diluted earnings per share | 0 | 0 | 0 | 0.00%-0.02 | -0.01 | 0 | 0 | 0 | -100.00%-0.02 | 0 |
| Basic earnings per share | 0 | 0 | 0 | 0.00%-0.02 | -0.01 | 0 | 0 | 0 | -100.00%-0.02 | 0 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.